1627 studies found for:    Open Studies | "Lung Neoplasms"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Circulating Tumor DNA in Patients at High Risk for Lung Cancer
Conditions: Cancer of the Lung;   Lung Cancer;   Lung Neoplasms;   Adenocarcinoma of the Lung;   Non Small Cell Carcinoma of the Lung;   Small Cell Carcinoma of the Lung
Intervention:
2 Unknown  Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours
Conditions: Lung Neoplasms;   Lung Cancer
Intervention: Procedure: Fractionated Stereotactic Radiotherapy
3 Recruiting MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
Conditions: Lung Neoplasms;   Cancer of Lung;   Cancer of the Lung;   Lung Cancer;   Neoplasms, Lung;   Neoplasms, Pulmonary;   Pulmonary Cancer;   Pulmonary Neoplasms;   Metastatic Cancer to the Lung
Intervention: Procedure: Microwave ablation
4 Not yet recruiting Circulating Tumor Cells Using the ClearCell® FX EP+ System During the Course of Treatment for Lung Cancer
Conditions: Lung Cancer;   Lung Neoplasms;   Cancer of Lung;   Cancer of the Lung;   Neoplasms, Lung;   Neoplasms, Pulmonary;   Pulmonary Cancer;   Pulmonary Neoplasms;   Carcinoma, Non-small-cell Lung;   Adenocarcinoma;   Squamous Cell Carcinoma
Intervention:
5 Recruiting Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients
Conditions: Lung Neoplasms;   Lung Cancer
Intervention: Radiation: Radiation therapy
6 Recruiting Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers
Conditions: Adenocarcinoma of the Lung;   Extensive Stage Small Cell Lung Cancer;   Limited Stage Small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Intervention: Drug: Ponatinib
7 Not yet recruiting Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients
Conditions: Carcinoma;   Non-small-cell Lung Cancer;   Lung Neoplasms
Intervention:
8 Recruiting Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency
Condition: Lung Neoplasms Accompanied by Respiratory Function Insufficiency
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
9 Recruiting Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer
Conditions: Advanced Non-small Cell Lung Cancer;   Metastatic Non-small Cell Lung Cancer;   Lung Neoplasms
Interventions: Biological: Vigil™;   Drug: Nivolumab
10 Recruiting Trial of CRLX101, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
Conditions: Solid Tumors;   Small Cell Lung Carcinoma;   Carcinoma, Non-Small-Cell Lung;   Lung Neoplasms
Interventions: Drug: CRLX101;   Drug: olaparib
11 Recruiting CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy
Conditions: Malignant Lung Neoplasm;   Metastatic Malignant Neoplasm in the Lung;   Non-Small Cell Lung Carcinoma;   Stage IV Lung Cancer
Interventions: Radiation: Computed Tomography Perfusion Imaging;   Other: Laboratory Biomarker Analysis
12 Recruiting Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
Conditions: Non-small Cell Lung Cancer;   Advanced Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Hydroxychloroquine;   Drug: Bevacizumab
13 Recruiting Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Radiation: hypofractionated radiation therapy;   Drug: cisplatin;   Drug: etoposide;   Radiation: 3-dimensional conformal radiation therapy;   Other: laboratory biomarker analysis
14 Recruiting Biomarkers for Diagnosis of Lung Cancer
Conditions: Lung Cancer;   Lung Neoplasm
Intervention:
15 Recruiting Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
Conditions: Non-small Cell Lung Cancer Metastatic;   Small Cell Lung Carcinoma
Intervention: Other: therapeutic interventions
16 Recruiting Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
Condition: Lung Neoplasms
Intervention:
17 Recruiting Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Conditions: Small Cell Lung Carcinoma;   Non Small Cell Lung Carcinoma;   Irinotecan Sensitive Cancers
Interventions: Drug: Carfilzomib;   Drug: Irinotecan
18 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
19 Recruiting Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation
Conditions: Cachexia;   Fatigue;   Pulmonary Complications;   Radiation Toxicity;   Recurrent Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Behavioral: exercise intervention;   Procedure: pulmonary complications management/prevention;   Procedure: quality-of-life assessment;   Other: questionnaire administration
20 Recruiting Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer
Interventions: Drug: vitamin C;   Device: Modulated Electro-Hyperthermia (mEHT);   Other: Supportive care

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years